Real-World Experience Using Bimekizumab for the Treatment of Moderate-to-Severe Psoriasis From a Single Outpatient Dermatology Clinic

被引：3
|
作者：
Cirone, Katrina D. [1 ]
Lovegrove, Fiona E. [1 ,2 ,3 ]
机构：
[1] Western Univ, Schulich Sch Med & Dent, London, ON, Canada
[2] Lovegrove Dermatol, London, ON, Canada
[3] Lovegrove Dermatol, 207-140 Oxford St East, London, ON, Canada
来源：
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 2024年 / 28卷 / 01期
关键词：
bimekizumab; psoriasis; biological therapy; real-world data; systemic therapy; SEVERE PLAQUE PSORIASIS; DOUBLE-BLIND; MULTICENTER; EFFICACY; SAFETY;
D O I：
10.1177/12034754231217205
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：78 / 79
页数：2
相关论文
共 50 条
  • [1] Bimekizumab for the treatment of moderate to severe psoriasis: a real-world experience over 52 weeks from two Italian dermatology clinics
    Mortato, E.
    Artosi, F.
    Borselli, C.
    Compagnucci, I.
    Rivieccio, Antonia
    Lanna, C.
    Lambiase, S.
    Gaeta Shumak, R.
    Loconsole, F.
    Bianchi, L.
    Campione, E.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
  • [2] Effectiveness of long-term bimekizumab treatment and predictive factors for responders in moderate-to-severe psoriasis: A 52-week real-world study
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    JOURNAL OF DERMATOLOGY, 2025, 52 (02) : 317 - 328
  • [3] Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis
    Zozaya, Neboa
    Abdalla, Fernando
    Zamora, Santiago Alfonso
    Filgueiras, Jesus Balea
    Carrascosa Carrillo, Jose Manuel
    Sanchez, Olga Delgado
    Sinisterra, Francisco Dolz
    Garcia-Ruiz, Antonio
    Pinto, Pedro Herranz
    Manfredi, Antonio
    Olmos, Jose Martinez
    de los Rios Luna, Paloma Morales
    Puig, Lluis
    Ros, Sandra
    HIdalgo-Vega, Alvaro
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (06) : 941 - 953
  • [4] Real-world efficacy and safety of apremilast monotherapy in the management of moderate-to-severe Psoriasis
    Shah, Bela J.
    Mistry, Deval
    Chaudhary, Navin
    Shah, Shikha
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2020, 11 (01) : 51 - 57
  • [5] Real-world experience with brodalumab in a Portuguese cohort of patients with moderate-to-severe psoriasis
    Torres, Tiago
    Mendes-Bastos, Pedro
    Antunes, Joana
    Cruz, Maria Joao
    Mota, Fernando
    Ferreira, Paulo
    DRUGS IN CONTEXT, 2025, 14
  • [6] Real-world data on the use of secukinumab as treatment for moderate-to-severe psoriasis in Chinese patients
    He Huang
    Ming-Long Cai
    Xiao-Jie Hong
    Li-Jun Zheng
    Zhu-Lin Hu
    Tao Yuan
    Wei-Ran Li
    Yu-Jun Sheng
    Xue-Jun Zhang
    European Journal of Dermatology, 2020, 30 : 554 - 560
  • [7] Real-world data on the use of secukinumab as treatment for moderate-to-severe psoriasis in Chinese patients
    Huang, He
    Cai, Ming-Long
    Hong, Xiao-Jie
    Zheng, Li-Jun
    Hu, Zhu-Lin
    Yuan, Tao
    Li, Wei-Ran
    Sheng, Yu-Jun
    Zhang, Xue-Jun
    EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (05) : 554 - 560
  • [8] Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting
    Ogut, Neslihan Demirel
    Yildirim, Sema Koc
    Erbagci, Ece
    Hapa, Fatma Asli
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (11) : 6215 - 6224
  • [9] Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: a meta-analysis of randomized clinical trials
    Wang, Yuqian
    Li, Sheng
    Bai, Juan
    Cai, Xiaoxuan
    Tang, Shunli
    Lin, Peiyi
    Sun, Qingmiao
    Qiao, Jianjun
    Fang, Hong
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2023, 14
  • [10] Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian Centers
    Vender, Ronald B.
    Lynde, Charles W.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2022, 26 (03) : 267 - 273
12345